Effect of Arginine and Glutamine on Radiation-induced Oral Mucositis: a Trible Blinded Randomized Controlled Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 20, 2023

Primary Completion Date

June 20, 2024

Study Completion Date

September 20, 2024

Conditions
Radiation MucositisHead and Neck Cancer
Interventions
DIETARY_SUPPLEMENT

Glutamine Oral Suspension

Participants in this group will receive an oral suspension containing 5 grams of glutamine dissolved in cold water. This solution is administered 30 minutes before meals, three times per day, using the swish and swallow technique throughout the radiotherapy period. This control intervention serves to compare the effects of glutamine alone with the combined arginine and glutamine treatment. In addition to the glutamine suspension, patients in this group will receive general measures and analgesic drugs according to the WHO scale to manage symptoms of mucositis.

DIETARY_SUPPLEMENT

Arginine and Glutamine Oral Suspension

Participants in this group will receive an oral suspension containing 5 grams of arginine and 5 grams of glutamine dissolved in cold water. This solution is administered 30 minutes before meals, three times per day, using the swish and swallow technique throughout the radiotherapy period. The swish and swallow technique involves patients swishing the solution around the oral mucosa to ensure even distribution before swallowing. This intervention aims to evaluate the combined effect of arginine and glutamine on reducing the severity of radiation-induced mucositis, improving mucosal healing, and providing symptomatic relief.

Trial Locations (1)

11277

Ahmed Maher Teaching Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06764420 - Effect of Arginine and Glutamine on Radiation-induced Oral Mucositis: a Trible Blinded Randomized Controlled Clinical Trial | Biotech Hunter | Biotech Hunter